| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.002 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |